Toby Cosgrove

Policy

AtriCure gets FDA nod to try hybrid atrial fibrillation procedure

Updated 8:10 p.m., May 10, 2010. Atricure Inc. (NASDAQ: ATRC), the maker of cardiac surgical ablation systems, has received a conditional nod from the Food and Drug Administration (FDA) to evaluate the safety and efficacy of a hybrid procedure to treat patients with persistent forms of atrial fibrillation. The hybrid procedure “represents a key growth […]

Hospitals

Cleveland Clinic to spend $848M on renovations, expansions in 2010, CEO says

The Cleveland Clinic plans to spend a whopping $848 million on renovations and construction of its health system this year, in addition to looking for more ways to expand nationally and internationally, Dr. Delos "Toby" Cosgrove, the Clinic's president and chief executive, said during his State of the Clinic speech Thursday morning. The spending plans come at a time when the Clinic is beginning to feel the effects of the recession.

News

AtriCure gets European OK for company-critical AtriClip System

AtriCure had tied much of its future success to the AtriClip. Minimally invasive product revenue has fallen at AtriCure in part because of a change in techniques among physicians that's not compatible with some of the company's products. The AtriClip accommodates the "single clamp" approach. Plus, the company thinks this device can also be used for open-heart procedures.

presented by
Hospitals

Health-care reform debate has narrowed to debate over insurance reform, says Dr. Toby Cosgrove

The Cleveland Clinic was health-reform neutral when President Barack Obama came to town a few weeks ago to hold a town hall meeting on efforts to reform the nation's health care system. But Clinic President and CEO Dr. Toby Cosgrove now is taking a stand, saying he's concerned that the reform debate has narrowed to health insurance rather than the entire health-care system, according to an interview published in Newsweek on Friday.